Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00701_DB01198_nanopub.RAP4S9WMfNft5S86ueUf2SQDYWsIF37XT1XODBCxdI-DE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00701_DB01198 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00701_DB01198 label "DDI between Amprenavir and Zopiclone - Amprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if amprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00701_DB01198]" assertion.
- drugbank_resource:DB00701_DB01198 identifier "drugbank_resource:DB00701_DB01198" assertion.
- drugbank_resource:DB00701_DB01198 title "DDI between Amprenavir and Zopiclone - Amprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if amprenavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00701 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00701_DB01198 assertion.
- drugbank:DB01198 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00701_DB01198 assertion.